Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Sareum Holdings PLC Logo
Sareum Holdings PLC Growth Score
87
CB Rank
208968
Heat Score
64
Sareum is a drug discovery company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on cancer
Founded
obfuscation
PublicPost-IPO Equity Pampisford, Cambridgeshire, United Kingdom1-10 www.sareum.com/
Biotechnology
Pharmaceutical
Therapeutics
Overview

Sareum Holdings PLC
Total Funding
obfuscation
Growth Score
87
Heat Score
64

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score87
-4 pts
in past quarter
Heat Score 64
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Sareum Holdings PLC

CB Rank
208968
Sareum is a drug discovery company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on cancer
Founded
obfuscation
PublicPost-IPO Equity Pampisford, Cambridgeshire, United Kingdom1-10 www.sareum.com/
Biotechnology
Pharmaceutical
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Sareum Limited
Also Known As Sareum Holdings
Operating Status Active
Stock Symbol  LSE:SAR
Company Type For Profit
Founders  David Williams, Tim Mitchell
About the Company
Sareum is a drug discovery company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on cancer and auto-immune disease. Sareum aims to successfully deliver drug candidates for licensing to pharmaceutical and biotechnology companies at the pre-clinical or early clinical trials stage.
Phone Number +44 0122-349-7700
Contact Email info@sareum.co.uk
Predictions & Insights

Products & Services

SDC-1801
A potent and selective TYK2/JAK1 inhibitor developed for treating autoimmune diseases, particularly psoriasis.
SDC-1802
A TYK2/JAK1 inhibitor under development for cancer and cancer immunotherapy applications.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Sareum Holdings PLC Logo
Post-IPO Equity - Sareum Holdings PLC
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sareum Holdings PLC Logo
Post-IPO Equity - Sareum Holdings PLC
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sareum Holdings PLC Logo
Post-IPO Equity - Sareum Holdings PLC
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sareum Holdings PLC Logo
Post-IPO Equity - Sareum Holdings PLC
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sareum Holdings PLC Logo
Post-IPO Equity - Sareum Holdings PLC
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Sareum Holdings PLC Logo
Post-IPO Equity - Sareum Holdings PLC
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sareum Holdings PLC Logo
Post-IPO Equity - Sareum Holdings PLC
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sareum Holdings PLC Logo
Post-IPO Equity - Sareum Holdings PLC
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sareum Holdings PLC Logo
Post-IPO Equity - Sareum Holdings PLC
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Sareum Holdings PLC Logo
Post-IPO Equity - Sareum Holdings PLC
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Tooru Logo
Tooru
Yes
Post-IPO Debt - Sareum Holdings PLC Logo
Post-IPO Debt - Sareum Holdings PLC
—
Tooru Logo
Tooru
Yes
Post-IPO Debt - Sareum Holdings PLC Logo
Post-IPO Debt - Sareum Holdings PLC
—
Tooru Logo
Tooru
Yes
Post-IPO Debt - Sareum Holdings PLC Logo
Post-IPO Debt - Sareum Holdings PLC
—
Tooru Logo
Tooru
Yes
Post-IPO Debt - Sareum Holdings PLC Logo
Post-IPO Debt - Sareum Holdings PLC
—
Tooru Logo
Tooru
Yes
Post-IPO Debt - Sareum Holdings PLC Logo
Post-IPO Debt - Sareum Holdings PLC
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News

News and Press

News•Oct 11, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 15, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 15, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 5, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

404
146.34%
 in past month

IT Spend

$43.6KThis year, Sareum Holdings PLC is projected to spend $43.6K on IT, according to Aberdeen.

Actively Used Products

12Sareum Holdings PLC uses 12 technology products and services including HTML5, jQuery, and  Google Analytics, according to G2 Stack.

Active Website Tech Count

9Sareum Holdings PLC is actively using 9 technologies for its website, according to BuiltWith. These include SSL by Default, CommonCrawl Top 50m, and  DNSSEC.

Total IP

16The intellectual property of Sareum Holdings PLC includes 16 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Sareum Holdings PLC's headquarters? Sareum Holdings PLC is located in Pampisford, Cambridgeshire, United Kingdom.Who invested in Sareum Holdings PLC? Sareum Holdings PLC is funded by Tooru.When was the last funding round for Sareum Holdings PLC? Sareum Holdings PLC closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Sareum Holdings PLC's competitors? Alternatives and possible competitors to Sareum Holdings PLC may include Avenzo Therapeutics, Alumis, and  Immuneering.How much funding has Sareum Holdings PLC raised to date? Sareum Holdings PLC has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(250d0b0 1)
|